Allergan reports second-quarter loss of $243.1 million

IndustriesAssociated Press

Allergan PLC (AGN) on Thursday reported a second-quarter loss of $243.1 million, after reporting a profit in the same period a year earlier.

On a per-share basis, the Dublin-based company said it had a loss of 80 cents. Earnings, adjusted for non-recurring costs, came to $4.41 per share.

Continue Reading Below

The results matched Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was also for earnings of $4.41 per share.

The drugmaker posted revenue of $5.76 billion in the period.

Allergan shares have increased 31 percent since the beginning of the year, while the Standard & Poor's 500 index has increased 2 percent. The stock has climbed 57 percent in the last 12 months.

_____

This story has been corrected to show the name of the company is Allergan, not Activis. The company changed its name in last month.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AGN at http://www.zacks.com/ap/AGN

_____

Keywords: Allergan, Earnings Report